Quest Diagnostics hit after hours on guidance cut

Ahead of its Investor Day tomorrow, Quest Diagnostics (NYSE:DGX) announces key strategic objectives and updated 2018 guidance.

It plans to derive at least 2% of its compounded average annual growth (CAGR) through acquisitions.

Quarterly dividend increased to $0.53 per share (from $0.50).

2018 outlook: Revenues: ~$7.57B from ~$7.62B; EPS: >$5.34 from $5.57 – 5.64; non-GAAP EPS (ex-depreciation): >$6.30 from $6.53 – 6.60; cash flow ops: ~$1.25B from ~$1.30B.

Shares are down 2% after hours.

https://seekingalpha.com/news/3412969-quest-diagnostics-2-percent-hours-guidance-cut